 | Cullinan Oncology, Inc. | |||
| NMS : CGEM || Location: United States | ||||
$24.33+5.08 (+26.39%) |
2.59 M | 19.27 - 25.72 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| April 15, 2024 | 1.678 M |
| March 28, 2024 | 1.436 M |
| March 15, 2024 | 0.935 M |
| Feb. 29, 2024 | 0.694 M |
| Feb. 15, 2024 | 0.784 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.98 | -0.54 | 44.94% |
| 09/30/2023 | -0.94 | -0.91 | 3.20% |
| 06/30/2023 | -0.99 | -0.82 | 17.12% |
| 03/31/2023 | -1.00 | -1.42 | -42.06% |
| 12/31/2022 | -0.68 | -0.59 | 13.02% |
CGEM Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 43.066M | Shares Float | 25.875M |
| Short Float | 1.678M | Market Cap | 829.02M |
| Institution ownership | 95.32% | Insider ownership | 6.397% |
| Earnings Date | 05/09/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -3.69 | Forward EPS | -3.09 |